Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2019

Schedule of fair value of assets acquired and liabilities assumed

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:



In millions
Cash and cash equivalents	$	6,565
Accounts receivable	4,094
Other current assets	3,894
Investments (current and long-term)	17,984
Goodwill	47,755
Intangible assets	22,571
Other assets	8,249
Total assets acquired	111,112
Health care costs payable	5,302
Other current liabilities	9,940
Debt (current and long-term)	8,098
Deferred income taxes	4,608
Other long-term liabilities	13,078
Total liabilities assumed	41,026
Noncontrolling interests	320
Total consideration transferred	$	69,766

Schedule of pro forma financial information

The following unaudited pro forma information presents a summary of the Company’s combined operating results for the years ended December 31, 2018 and 2017 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2017. The following pro forma financial information is not necessarily indicative of the Company’s operating results as they

would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.



	Year Ended December 31,
In millions, except per share data	2018		2017
Total revenues	$	243,232	$	236,000
Income from continuing operations	1,152		6,813
Basic earnings per share from continuing operations attributable to CVS Health	$	0.89	$	5.25
Diluted earnings per share from continuing operations attributable to CVS Health	$	0.88	$	5.21